Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

NeutriSci International Inc. (V:NU)

Business Focus: Special Foods & Wellbeing Products

Jan 04, 2023 08:04 pm ET
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Jan. 4, 2023 /CNW/ -
Jun 07, 2022 03:15 am ET
NEUTRISCI SHIPS ORDER TO TABLETZ DISTRIBUTION PARTNER
VANCOUVER, BC, June 7, 2022 /CNW/ - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has shipped an additional order to Tabletz LLC.
Jan 26, 2022 04:04 pm ET
NEUTRISCI ANNOUNCES VOLUNTARY DELISTING FROM OTCQB
VANCOUVER, BC, Jan. 26, 2022 /CNW/ - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, announces that, it in order to direct capital to other activities, will voluntarily delist its common shares from trading on the OTCQB.  The delisting will be effective prior to the opening of the markets on February 1, 2022.
Jan 18, 2022 02:15 am ET
NEUTRISCI SHIPS TABLETZ ORDER TO JAPAN
VANCOUVER, BC, Jan. 18, 2022 /CNW/ - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has shipped another order that was placed by Tabletz LLC, via air freight to Japan. The respective revenue will be booked in the current quarter.
Jan 04, 2022 02:15 am ET
NEUTRISCI SIGNS EXCLUSIVE 5-YEAR DISTRIBUTION AGREEMENT FOR EUROPE AND RECEIVES INITIAL ORDER
VANCOUVER, BC, Jan. 4, 2022 /CNW/ - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce that it has executed a definitive agreement (the "Agreement") with TH International Consulting GmbH ("THIC") for the distribution of neuenergy™ in Europe.  Founded in 2012 and based in Esslingen, Germany, THIC is successfully active in the areas of consulting, marketing, as well as direct marketing.
Dec 17, 2021 07:03 pm ET
NEUTRISCI UPDATES MANAGEMENT DISCUSSION AND ANALYSIS'
VANCOUVER, BC, Dec. 17, 2021 /CNW/ - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU) (OTCQB: NRXCF) (FSE: 1N9), announces that as a result of a review by the British Columbia Securities Commission it has refiled its management discussion & analysis for the six- and nine-month periods ended June 30, 2021 and September 30, 2021 (collectively, the "MD&A").  The refiled MD&A includes additional disclosure regarding a one-time financial loss incurred by the Company, and which was already reflected in the accompanying interim financial statements for these perio
Nov 30, 2021 03:15 am ET
NeutriSci Announces Successful Completion of R&D in Preparation for Launch of Its Functional Mushroom Product Line
VANCOUVER, BC / ACCESSWIRE / November 30, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that is has successfully completed the R&D of a newly developed effervescent functional mushroom tablet product for online sales in Europe and North America.
Oct 12, 2021 03:15 am ET
NeutriSci Provides Production Update and Partner Progress
VANCOUVER, BC, Oct. 12, 2021 /CNW/ - NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP, and technology for B2B partnerships and the nutraceutical industry, is pleased to provide the following update.
Sep 22, 2021 02:10 pm ET
NeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution Partner
VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has received an additional order from Tabletz LLC.
Sep 10, 2021 03:50 pm ET
NeutriSci Arranges Strategic Financing with Tabletz and Exercise of Warrants
VANCOUVER, BC / ACCESSWIRE / September 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, licencing IP, and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has arranged a non-brokered private placement (the "Placement") and the exercise of 4,900,000 warrants, for total combined proceeds of $276,550.
Aug 12, 2021 03:15 am ET
Neutrisci Provides Update on Tabletz Developments
VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to provide an update on previously announced projects.
Jul 07, 2021 03:15 am ET
Neutrisci Provides Update on Tabletz and Previously Announced Project Development
VANCOUVER, BC / ACCESSWIRE / July 7, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to provide an update on previously announced projects.
Jun 23, 2021 02:50 pm ET
NeutriSci Provides Update On Biople Product Launch In Japan
VANCOUVER, BC / ACCESSWIRE / June 23, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU) (OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its partner, Tabletz LLC, is pleased to update details regarding the Biople launch of the TABLETZ brand in Japan.
Jun 09, 2021 03:15 am ET
May 27, 2021 03:15 am ET
NeutriSci Completes R&D and Expands Product Selection to Include Beverages
VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT: 1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has completed the R&D required to successfully create functional beverages using its IP and Technology to enter the CBD beverage market.
May 25, 2021 03:15 am ET
NeutriSci and Pacwest Announce Technology and IP Arrangement for R&D Product Development
VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce the completion of an arrangement with its manufacturing partner, Pacwest Manufacturing Group Inc. ("Pacwest"), to provide the use of its NeutriSci's IP and technology to assist Pacwest's development of several
May 10, 2021 03:15 am ET
Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product
VANCOUVER, BC / ACCESSWIRE / May 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce the Phase 1 R&D completion of a newly developed Cannabinol (CBN) product for the US marketplace. In conjunction with its contract manufacturing partner Pacwest, the completion of Phase 1 used NeutriSci's IP, technologies, and ingredients to create a finished CBN tab
May 03, 2021 03:15 am ET
Neutrisci Receives Additional Order for Japanese Market
VANCOUVER, BC / ACCESSWIRE / May 3, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that Tabletz LLC. has placed an additional order for the TABLETZ product that will be delivered to a specific retailer in Japan.
Mar 18, 2021 03:15 am ET
Neutrisci Announces New State-Of-The-Art Production and Research Facility in Las Vegas, Nevada, USA
VANCOUVER, BC / ACCESSWIRE / March 18, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce the completion of its newly dedicated production line and research lab in Las Vegas, Nevada. The production line and lab (the "NeutriSci Facility") has been built within the manufacturing facility of NeutriSci's manufacturing partner and is designed
Mar 08, 2021 03:15 am ET
NeutriSci: Harmonized Code Approval Received by TABLETZ LLC., in Japan
VANCOUVER, BC / ACCESSWIRE / March 8, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its partner, Tabletz LLC, is very pleased to announce that its partner Tabletz LLC. has received approval and classification for a Harmonized Code (HS Code) for the TABLETZ product from Japanese customs. The classification is within the candy category and the HS code is 2106.90.299.
Jan 29, 2021 06:45 pm ET
NeutriSci Closes Financing
VANCOUVER, BC / ACCESSWIRE / January 29, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that it has closed a non-brokered private placement (the "Placement") in which it raised gross proceeds of $370,050.
Jan 18, 2021 03:15 am ET
NeutriSci Receives Multi Million Dollar Order for Japanese Market
VANCOUVER, BC / ACCESSWIRE / January 18, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce the details regarding its first large order for the TABLETZ brand in Japan.
Dec 14, 2020 03:15 am ET
NeutriSci’s Contract Partner, Tabletz LLC, Provides Update on Product Launch in Japan
VANCOUVER, BC / ACCESSWIRE / December 14, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with partner, Tabletz LLC, is pleased to update details regarding the launch of the TABLETZ brand in Japan.
Oct 28, 2020 03:15 am ET
Neutrisci Provides Update on Product Launch in Japan
VANCOUVER, BC / ACCESSWIRE / October 28, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its partner, Tabletz LLC, is very pleased to update details regarding the launch of the TABLETZ brand in Japan.
Oct 15, 2020 03:15 am ET
NeutriSci Enters the Second Highest Grossing Market with New Distribution in the State of Washington
VANCOUVER, BC / ACCESSWIRE / October 15, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce that Cryopharm Corp. ("Cryopharm"), its US manufacturing and distribution partner, will begin the distribution of NeutriSci's and Cryopharm's CBD & THC products into the state of Washington.
Oct 08, 2020 03:10 pm ET
Neutrisci Partner Tabletz LLC Launches Website and Social Media Platforms to Conquer Japanese CBD Market
VANCOUVER, BC / ACCESSWIRE / October 8, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its partner, Tabletz LLC., is very pleased to announce details of the TABLETZ brand that will be launched in Japan this month (October 2020).
Sep 28, 2020 11:20 am ET
NeutriSci Provides Corporate Update
NeutriSci's Japan partner doing big "soft-launch" event on October 8/9
Aug 31, 2020 03:15 am ET
NeutriSci Provides Corporate Update on Contract Partner, New Markets and Product Line
VANCOUVER, BC / ACCESSWIRE / August 31, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its manufacturing partner, Cryopharm, is pleased to announce new market entrance and the details of the release of new product lines in October 2020.
Aug 12, 2020 03:15 am ET
NeutriSci Provides Update Regarding Product Launch in California
VANCOUVER, BC / ACCESSWIE / August 12, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is pleased to announce that Cryopharm Corp. ("Cryopharm" - www.cryopharm.com), its US manufacturing and distribution partner; will begin the distribution of NeutriSci and Cryopharm's CBD & THC products into
Aug 04, 2020 03:15 am ET
Neutrisci Receives Final Approval from The Japanese Health Ministry
VANCOUVER, BC / ACCESSWIRE / August 4, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to provide a further update regarding its entry into the promising Japanese CBD market.
Jul 16, 2020 02:09 pm ET
IIROC Trading Resumption - NU
VANCOUVER, BC, July 16, 2020 /CNW/ - Trading resumes in:
Jul 16, 2020 02:00 pm ET
NeutriSci Signs Exclusive 5-Year Distribution Agreement for Japan
VANCOUVER, BC / ACCESSWIRE / July 16, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to provide a further update regarding its entry into the promising Japanese CBD market.
Jul 16, 2020 10:17 am ET
IIROC Trading Halt - NU
VANCOUVER, BC, July 16, 2020 /CNW/ - The following issues have been halted by IIROC:
Jul 03, 2020 10:40 pm ET
NeutriSci Retracts July 3rd News Release
VANCOUVER, BC / ACCESSWIRE / July 3, 2020 / NeutriSci International Inc. (the "Company" or "NeutriSci") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9) announces that its news release issued on July 3, 2020 with respect to a debt settlement was issued in error and shareholders should disregard the earlier disclosure.
Jul 03, 2020 03:15 pm ET
NeutriSci to Complete Share Settlement
VANCOUVER, BC / ACCESSWIRE / July 3, 2020 / NeutriSci International Inc. (the "Company" or "NeutriSci") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9) , an innovative technology company developing products for the nutraceutical industry, announces that it will issue 2,060,534 common shares, at a deemed price of $0.05 per share, in settlement of US$75,833 in consulting services fees for strategic planning, market intelligence initiatives, research, and business referrals owing in connection with an agreement entered into with an arm's length third party on May 29
Jun 30, 2020 03:05 am ET
NeutriSci Significantly Increasing Manufacturing Output Capacity To Meet Anticipated Demand From Japanese Market
VANCOUVER, BC / ACCESSWIRE / June 30, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to provide a further update regarding its entry into the promising Japanese CBD market.
Jun 09, 2020 09:10 am ET
Initial Order Sees NeutriSci Enter Promising Japanese CBD Market
VANCOUVER, BC / ACCESSWIRE / June 9, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) is very pleased to announce that it has entered the Japanese CBD market with a strategic private label partnership. An initial sample order with a value of $37,500.00 USD has been received and paid. The name and brand will be disclosed upon the completion of a definitive agreement, which is expected within the next 30 working days.
Mar 13, 2020 02:55 pm ET
Distribution of NeutriSci's THC/CBD Products to Commence in California
VANCOUVER, BC / ACCESSWIRE / March 13, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (OTCQB:NRXCF)(TSXV:NU)(FRANKFURT:1N9) is pleased to announce that Cryopharm Corp. ("Cryopharm"), its US manufacturing and distribution partner, is completing the packaging of NeutriSci and Cryopharm's CBD/THC products in preparation for initial distribution to more than 90 dispensaries across the state of California, with the distribution network expected to grow to over 350 dispensaries in Q2/2020.
Mar 05, 2020 05:45 pm ET
NeutriSci Closes $518,000 Financing
VANCOUVER, BC / ACCESSWIRE / March 5, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9) the innovator and pioneer behind neuenergy® is pleased to announce that it has closed on the final tranche of its non-brokered private placement (the "Placement") announced on January 16, 2020 and February 18, 2020, in which it raised proceeds of $518,000.
Feb 18, 2020 12:15 pm ET
NeutriSci Increases Financing To $1.15 Million
VANCOUVER, BC / ACCESSWIRE / February 18, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT:1N9) the innovator and pioneer behind neuenergy® is pleased to announce that it has elected to increase the size of the non-brokered private placement (the "Placement") originally announced on January 16, 2020. On January 24, 2020, the Company closed on the first tranche of the Placement, in which it raised proceeds of $655,000. Due to increased investor de
Jan 24, 2020 02:45 pm ET
NeutriSci Closes $655,000 Financing
VANCOUVER, BC / ACCESSWIRE / January 24, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT:1N9) the innovator and pioneer behind neuenergy® is pleased to announce that it has closed on the first tranche of its non-brokered private placement (the "Placement") announced on January 16, 2020, in which it raised proceeds of $655,000.
Jan 16, 2020 03:05 pm ET
NeutriSci Withdraws Share Consolidation and Plans $0.05 Private Placement Financing
VANCOUVER, BC / ACCESSWIRE / January 16, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF), (FRANKFURT:1N9) the innovator and pioneer behind neuenergy® is pleased to announce that it will not be proceeding with the proposed financing or consolidation as announced on December 18, 2019.
Sep 12, 2019 01:28 pm ET
NeutriSci Expands Partnership With Cryopharm and Nutritional High
NeutriSci International Inc. ("NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® is pleased to announce that it has expanded its previously announced partnerships with Cryopharm Corporation...
Jun 19, 2019 08:30 am ET
NeutriSci Announces Initial Order From Cryopharm
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that it has received an initial order from Cryopharm Corporation...
May 15, 2019 08:30 am ET
NeutriSci and Thai Freeze Dry Join Forces to Develop New Product Line of Cannabis Edibles
NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and Thai Freeze Dry Co. Ltd. (“TFD”) are pleased to announce they have entered into a Letter of...
May 02, 2019 08:30 am ET
NeutriSci International Announces Exclusive Distribution Deal
NeutriSci International Inc. ("NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® is pleased to announce effective May 1st, 2019 ANB Canada Inc. (“ANB”) will assume all responsibilities for retail...
Mar 25, 2019 08:30 am ET
NeutriSci Enters Into LOI With Falcon Technologies Inc. dba Eco-Growth Strategies to Manufacture Sublingual CBD Products
Neutrisci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and Falcon Technologies, Inc. (“Falcon”) (FLCN:PINK) are pleased to jointly announce they have...
Mar 25, 2019 08:00 am ET
Falcon Technologies aka Eco-Growth Strategies Enters Into LOI With Neutrisci To Manufacture Sublingual CBD Products
SACRAMENTO, CA / ACCESSWIRE / March 25, 2019 / Neutrisci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and Falcon Technologies, Inc. ("Falcon") (FLCN:OTC PINK) are pleased to jointly announce they have entered into a Letter of Intent to create a sublingual CBD tablet.
Feb 26, 2019 08:30 am ET
Neutrisci Announces Product Sales Increase
Neutrisci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that it has received its first order for its sublingual cannabidiol (CBD)...
Dec 06, 2018 09:00 am ET
NeutriSci Announces Exclusive Licensing Agreement for CBD Tablet Manufacturing & Distribution With LaSanta Botanicals Ltd.
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) outlining the...
Oct 17, 2018 08:00 am ET
Neutrisci International and Nutritional High Announce Production and Distribution Update
NeutriSci International Inc. ("NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® and Nutritional High International Inc. (“Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) are pleased to...
Oct 11, 2018 08:00 am ET
NeutriSci and Naturally Splendid USA Announce Expanded Binding Terms of Partnership and Added Distribution of HempOmega™ and Cannabidiol (CBD) Sublingual Tablets
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to provide a further update on its previously announced non-binding letter of intent (“LOI”) between the Company and Naturally Splendid...
Oct 11, 2018 07:30 am ET
Naturally Splendid USA and NeutriSci Announce Expanded Binding Terms of Partnership and Added Distribution of HempOmega™ and Cannabidiol (CBD) Sublingual Tablets
NATURALLY SPLENDID ENTERPRISES LTD. (TSX-V: NSP)(OTCQB: NSPDF) (“Naturally Splendid” or “NSE” or the “ Company” or “Naturally Splendid USA”) is pleased to provide a further update on its previously announced non-binding Letter of Intent (“LOI”)...
Jul 10, 2018 11:08 am ET
Nutritional High and NeutriSci International to Launch Cannabis-Infused Tablets July 11th
NeutriSci International Inc. ("NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy® is pleased to provide an update on its previously announced partnership with Nutritional High International Inc. (the...
Jul 10, 2018 09:09 am ET
Nutritional High and NeutriSci to Launch Cannabis-Infused Nu Energy Tablets July 11th
Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased to provide an update on its previously announced partnership with NeutriSci International Inc. ("NeutriSci") (TSX-V:NU)...
Jun 04, 2018 09:00 am ET
NeutriSci Provides Update on Patent Pending Technology
NeutriSci International Inc. ("NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy®, is pleased to announce advancements with its patent pending  technology, trade named “Cryolisation”.  The Cryolisation...
May 30, 2018 09:00 am ET
NeutriSci and Nutritional High Enter Into Agreement to Develop, Manufacture & Distribute Cannabis Infused Products
NeutriSci International Inc. ("NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy®, and Nutritional High International Inc. (“Nutritional High) (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU), are pleased to...
May 30, 2018 07:54 am ET
NeutriSci and Nutritional High Enter Into Agreement to Develop, Manufacture & Distribute Cannabis Infused Products
NeutriSci International Inc. ("NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy®, and Nutritional High International Inc. (“Nutritional High) (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU), are pleased to...
Apr 19, 2018 08:30 am ET
Neutrisci Announces Partnership With Rogers Cup Presented by National Bank
VANCOUVER, British Columbia, April 19, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that it has entered into a sponsorship partnership with...
Mar 05, 2018 08:30 am ET
NetworkNewsAudio Covers New Patent Application of NeutriSci International Inc. (TXS-V:NU) (OTCQB:NRXCF)
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for business, today announces the audio version of a press release from NeutriSci International Inc. (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) titled “NeutriSci Files Patent...
Mar 01, 2018 08:30 am ET
Neutrisci Files Patent Application
Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci")  the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new U.S. provisional patent application (United States Provisional Patent No. 62/628,735; Compositions Comprising Co-crystals of Stilbenoids and Cannabinoids) relating to compositions comprising pterostilbene and other stilbenoids in formulations which improve the dissolution rate and bioavailability of cannabinoid compounds.
Mar 01, 2018 08:30 am ET
NeutriSci Files Patent Application
VANCOUVER, British Columbia , March 01, 2018 (GLOBE NEWSWIRE) -- via NetworkWire - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new...
Mar 01, 2018 08:00 am ET
NeutriSci Files Patent Application
VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new U.S. provisional patent application...
Feb 28, 2018 08:30 am ET
NetworkNewsAudio Covers Global Licensing Agreement of Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP) and NeutriSci International Inc. (TXS-V:NU) (OTCQB:NRXCF)
NEW YORK , Feb. 28, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for business, today announces the audio version of Lexaria Bioscience Corp.’s (CSE:LXX) (OTCQX:LXRP) recent press release: “Lexaria Bioscience Corp....
Feb 26, 2018 08:31 am ET
Neutrisci and Lexaria Bioscience Enter Global Licensing Agreement
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci") and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) ("Lexaria") are pleased to announce that they have revised their joint venture agreement such that NeutriSci now owns 100% of Ambarii Trade Corporation ("Ambarii"), and Lexaria has granted to NeutriSci, an Intellectual Property License and Supply Agreement (the "License Agreement") for the manufacturing and sale of CBD based products.
Feb 26, 2018 08:30 am ET
NeutriSci and Lexaria Bioscience Enter Global Licensing Agreement
VANCOUVER, British Columbia, Feb. 26, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) and Lexaria Bioscience Corp. (“Lexaria”) (CSE:LXX) (OTCQX:LXRP) are pleased to announce that they have revised their joint venture agreement...
Feb 26, 2018 08:30 am ET
NeutriSci and Lexaria Bioscience Enter Global Licensing Agreement
VANCOUVER, British Columbia , Feb. 26, 2018 (GLOBE NEWSWIRE) --
Feb 26, 2018 03:20 am ET
Lexaria and Neutrisci Enter Global Licensing Agreement
KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / February 26, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces it has entered an agreement with NeutriSci International Inc. ("NeutriSci") (TSX-V: NU.V) (OTCQB: NRXCF) such that NeutriSci now owns 100% of Ambarii Trade Corporation ("Ambarii"), and Lexaria has granted to NeutriSci an Intellectual Property License and Supply Agreement (the "License Agreement") for the manufacturing and sale of CBD based products.
Feb 22, 2018 08:30 am ET
NeutriSci Named to the 2018 TSX Venture 50®
VANCOUVER, B.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) is pleased to announce it has been named to the 2018 TSX Venture 50®, an annual ranking of top-performing companies...
Jan 12, 2018 07:30 am ET
NetworkNewsAudio Covers NeutriSci International Inc.’s Release on Recent R&D MOU with Scientus Pharma
NEW YORK, Jan. 12, 2018 (GLOBE NEWSWIRE) -- NetworkNewsAudio, via NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the audio version of the press...
Jan 11, 2018 08:30 am ET
NeutriSci Announces Major Sponsorship With Tennis Star Genie Bouchard
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce a one-year sponsorship deal with Canadian and International tennis...
Jan 08, 2018 08:35 am ET
Neutrisci Announces a Major R&D MOU with Scientus Pharma to Develop a Medical Cannabinoid Retail Product
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci"), the innovator and pioneer behind neuenergy®, is pleased to announce it has entered into a major R&D Memorandum of Understanding with Scientus Pharma Inc. ("Scientus Pharma"). Under the terms of the MOU, both companies have agreed to share their technologies to develop, test, produce, and distribute a medical cannabinoid product for existing retail distribution networks across Canada.
Jan 08, 2018 08:30 am ET
NeutriSci Announces a Major R&D MOU With Scientus Pharma to Develop a Medical Cannabinoid Retail Product
VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9), the innovator and pioneer behind neuenergy®, is pleased to announce it has entered into a major R&D Memorandum of...
Jan 08, 2018 08:00 am ET
NeutriSci Announces a Major R&D MOU with Scientus Pharma to Develop a Medical Cannabinoid Retail Product
VANCOUVER, British Columbia, Jan. 08, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9), the innovator and pioneer behind neuenergy®, is pleased to announce it has entered into a major R&D Memorandum of...
Nov 06, 2017 08:00 am ET
NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation...
Jul 20, 2017 08:00 am ET
NeutriSci's Neuenergy(R) Launches in Quebec
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available at Sobeys gas bars and convenience...
Jul 07, 2017 11:47 am ET
NeutriSci Announces Warrant Incentive Program
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that it will immediately implement an incentive program designed to...
Jun 06, 2017 08:30 am ET
NeutriSci Announces International Distribution Agreement and Initial Orders Into China, Hong Kong, Taiwan and Macau
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce its first major distribution agreement for neuenergy® into Greater...
Jun 01, 2017 08:30 am ET
NeutriSci Adds Esso Gas Bars and Convenience Stores to Its List of Canadian Retailers
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Esso gas bars and convenience stores...
May 30, 2017 08:00 am ET
NeutriSci's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that its joint venture subsidiary, Ambarii Trade Corporation ("Ambarii") and Naturally Splendid Enterprises Ltd....
May 30, 2017 07:50 am ET
Lexaria's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea
Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that its 50%-owned joint venture subsidiary, Ambarii Trade Corporation ("Ambarii") has entered into a LOI with Naturally Splendid Enterprises Ltd....
May 02, 2017 04:35 pm ET
NeutriSci Completes Private Placement
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that it has completed a non-brokered private placement (the "Placement") in which it raised gross proceeds of...
Apr 10, 2017 08:30 am ET
NeutriSci Forms Cannabinoid Joint Venture With Lexaria Bioscience
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. ("Lexaria") (CSE: LXX) (OTCQB: LXRP) are pleased to announce finalization of the joint venture between the...
Apr 10, 2017 08:00 am ET
Lexaria and Neutrisci Enter Cannabinoid Joint Venture
Lexaria Bioscience Corp (OTCQB: LXRP) (CSE: LXX) (the "Company") and Neutrisci International Inc ("Neutrisci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) have completed and signed the previously announced joint venture agreement (the "JV") to...
Mar 30, 2017 08:30 am ET
NeutriSci Welcomes Olympic Gold Medalists Michelle Cameron Coulter and Al Coulter as Neuenergy Brand Ambassadors
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the addition of Olympic Gold medalists Michelle Cameron Coulter and Al...
Mar 29, 2017 08:30 am ET
NeutriSci Announces Advanced Talks With Several of Canada's Leading Medical Marijuana Companies
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, confirms it is in advanced discussions regarding product formulation with several of the top...
Mar 21, 2017 08:30 am ET
NeutriSci Announces Launch of New Ambassador Direct Sales Channel
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its ambassador marketing program for neuenergy®.The...
Mar 16, 2017 08:30 am ET
NeutriSci Announces Distribution Agreement & Initial Order of Neuenergy From Gateway Newstands
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available at Gateway Newstands across Canada and...
Mar 09, 2017 08:30 am ET
NeutriSci Launches National Television Ad Campaign
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its national television campaign for neuenergy®. The...
Mar 06, 2017 04:43 pm ET
NeutriSci Announces OTCQB Listing
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that it has commenced trading on the OTCQB Marketplace under the symbol NRXCF. NeutriSci President, Glen Rehman...
Jan 19, 2017 08:00 am ET
Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results From Initial Human Observational Trials
Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") and NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) are pleased to announce the successful development and initial trial of...
Jan 19, 2017 08:00 am ET
NeutriSci Announces Successful Development and Positive Results From Initial Observational Product Trials With Lexaria Bioscience
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. ("Lexaria") (CSE: LXX) are pleased to announce the successful development and initial trial of the industry's first...
Jan 17, 2017 08:30 am ET
NeutriSci Adds Sobeys & Safeway to Its List of Canadian Retailers
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Sobeys and Safeway Canada.Sobeys Inc. and Safeway Canada are...
Nov 28, 2016 08:30 am ET
NeutriSci Announces Initial Order of neuenergy From Mac's Convenience and Lucky Vitamin
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available through online retailer, Lucky Vitamin, and that...
Nov 22, 2016 09:43 am ET
NeutriSci Announces Memorandum of Understanding Establishing a 50/50 Joint Venture With Lexaria Bioscience
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. ("Lexaria") (CSE: LXX) (CSE: LXX.CN) are pleased to announce the signing of a Memorandum of Understanding forming a 50/50...
Oct 11, 2016 09:00 am ET
NeutriSci Adds Another Canadian Distributor With Winks Convenience -- Division of Mac's
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Winks Convenience stores.Winks is an affiliate retail banner...
Sep 28, 2016 09:00 am ET
NeutriSci Announces Canadian Distribution Agreement and Initial Order With Save-On-Foods
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) , the innovator and pioneer behind neuenergy™, announces its latest Canadian distribution agreement with Save-On-Foods, a subsidiary of the Overwaitea...
Sep 07, 2016 09:00 am ET
NeutriSci Announces International Distribution Agreement and Initial Orders
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy™, is pleased to announce its first European distribution agreement with Soletek GmbH, Germany ("Soletek")....
Aug 29, 2016 09:55 am ET
NeutriSci Announces Dual Listing on the Frankfurt Stock Exchange
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy™, is pleased to announce that the Company's shares have been accepted for trading on the Frankfurt Stock...
Jun 07, 2016 08:30 am ET
NeutriSci Announces Canadian Distribution Agreement and Initial Order With Shefield Group and Mac's Convenience Stores
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) the innovator and pioneer behind neuenergy™, announces its latest Canadian distribution agreements with Mac's Convenience Stores ("Mac's") and Shefield Group. Mac's is...
May 11, 2016 01:31 pm ET
NeutriSci Provides Operational Update
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) the innovator and pioneer behind neuenergy™, is pleased to provide a Canadian operational update.BuluBox.com has reported that neuenergy™ ranks near the top of their Best...
Apr 27, 2016 09:00 am ET
NeutriSci Announces Results of AGM, Adds John Bell and Arlene Dickinson to Board
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) the innovator and pioneer behind neuenergy™, is pleased to announce the results of its Annual General Meeting ("AGM") held on April 22, 2016. Glen Rehman, President,...
Apr 22, 2016 09:00 am ET
NeutriSci Announces Strategic Partnership With Venture Communications
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) the innovator and pioneer behind neuenergy™, is pleased to announce that it has entered into a strategic marketing and branding partnership with Venture Communications....
Mar 09, 2016 09:00 am ET
NeutriSci Announces Strategic Distribution Agreement With Wallace & Carey
NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) the innovator and pioneer behind NeuEnergy(TM), is pleased to announce that it has entered into a long term distribution agreement with Wallace & Carey Inc. ("Wallace & Carey").